330 J ournal of Natural Products, 2003, Vol. 66, No. 3
Fraga et al.
1 contained starting material 1 (1.5 mg). Fraction 2 was
purified by column chromatography on Si gel, using a n-hex-
ane-EtOAc gradient. Fractions eluted with n-hexane-EtOAc
(9:1) were purified by HPLC using a gradient of 35% EtOAc
to 55% in n-hexane, giving foliol 3 (4.8 mg). Fractions eluted
with n-hexane-EtOAc (85:15) were acetylated and purified by
HPLC using EtOAc as isocratic eluent to give foliol triacetate
(4) (2.3 mg). Chromatographic separation of the acetylated
fraction 3 afforded 4 (3.1 mg) and sideritriol triacetate 6 (1.3
mg). Fraction 4 was acetylated and purified by chromatogra-
phy on a Si gel column with a gradient of ethyl acetate-hexane
(4:1 to 1:1, v/v) and then by HPLC with a gradient of 30%
EtOAc to 50% in n-hexane to give the tetraacetate 9 (1 mg)
and the triacetate 8 (19.2 mg).
266 (58), 253 (100), 225 (40), 197 (19), 157 (25); HREIMS m/z
446.2726 [M - AcOH]+ (calcd for C26H38O6, 446.26683).
Biot r a n sfor m a t ion of Ca n d ica n d iol (2). Candicandiol
(7R,18-dihydroxy-ent-kaur-16-ene) (2) (230.8 mg) dissolved in
EtOH (8 mL) and 3 drops of Tween-80 was distributed among
40 conical flasks and incubated for a further 6 days. The
metabolites were isolated as above and chromatographed on
Si gel. Elution with n-hexane-EtOAc (3:2) gave starting
material 2 (84.6 mg). Further elution with n-hexane-EtOAc
(1:1) gave 7R,9â,18-trihydroxy-ent-kaur-16-ene (10) (2.5 mg).
Fractions eluted with n-hexane-EtOAc (1:4) were purified by
HPLC using EtOAc as isocratic eluent to give canditriol (11)
(3.4 mg). Acetylation of fractions eluted with EtOAc-MeOH
(1:1) and further chromatography on a Si gel column eluted
with n-hexane-EtOAc mixtures gave the tetraacetate 14 (9.1
mg) and the triacetate 13 (25.7 mg).
F oliol (3): colorless crystals; mp 194-197 °C (lit.20 198-
200 °C); IR (CHCl3) νmax 3350, 2930, 1045, 1020, 875, 755 cm-1
;
1H NMR (CDCl3, 500 MHz) δ 0.75 (3H, s, H-19), 0.97 (1H, dd,
J ) 12.7, 7.6, H-14â), 1.04 (3H, s, H-20), 1.15 (1H, dd, J )
11.4, 4.7 Hz, H-1â), 1.43 (1H, br s, H-9), 2.21 (2H, br s, H-15),
2.66 (1H, br s, H-13), 3.58 (1H, br s, H-7), 3.35 and 3.59 (each
1H, J ) 11.1 Hz, H-18), 3.68 (1H, dd, J ) 8.9 and 7.7 Hz, H-3),
4.77 and 4.81 (each 1H, s, H-17); EIMS m/z (rel int) 320 [M]+
(3), 302 (21), 284 (1), 272 (100), 253 (59), 211 (20), 199 (24),
157 (24); HREIMS m/z 320.23363 (calcd for C20H32O3 320.23514).
7r,9â,18-Tr ih ydr oxy-en t-kau r -16-en e (10): colorless prism;
mp 196-198 °C; IR (CHCl3) νmax 3400, 2920, 1460, 1380, 1290,
1
1055, 1025, 1005, 935, 860 cm-1; H NMR (CDCl3, 500 MHz)
δ 0.76 (3H, s, H-19), 1.17 (3H, s, H-20), 1.26 (1H, m, J ) 14
Hz, H-14), 1.50 (1H, m, H-1), 1.67 (2H, m, H-2 and H-12), 1.73
(2H, m, H-11), 1.89 (1H, dd, J ) 12.9, 1.9 Hz, H-5), 1.98 (1H,
dd, J ) 14.3, 5.7 Hz, H-14), 2.43 (1H, dt, J ) 17.6, 3 Hz, H-15â),
2.46 (1H, d, J ) 17.6 Hz, H-15R), 2.67 (1H, br s, H-13), 3.11
and 3.42 (each 1H, J ) 10.9 Hz, H-18), 3.81 (1H, dd, J ) 12,
4.3 Hz, H-7), 4.78 and 4.81 (each 1H, s, H-17); EIMS m/z (rel
int) 302 [M - H2O]+ (3), 290 (2), 284 (2), 271 (11), 253 (9), 163
(30), 123 (62), 109 (100), 93 (17), 81 (18); HREIMS m/z
302.2195 [M - H2O]+ (calcd for C20H30O2, 302.2246).
1
Tr ia ceta te (4): H NMR (CDCl3, 500 MHz) δ 0.80 (3H, s,
H-19), 1.06 (1H, m, H-1â), 1.08 (3H, s, H-20), 1.24 (1H, dd, J
) 11.6, 5.3 Hz, H-14), 1.48 (1H, d, J ) 6.8 Hz, H-9), 1.99 and
2.01 (each 3H, s, OAc), 2.09 (1H, dt, J ) 17, 3 Hz, H-15), 2.17
(1H, d, J ) 17 Hz, H-15), 2.68 (1H, br s, H-13), 3.51 and 3.90
(each 1H, d, J ) 11.6 Hz, H-18), 4.73 (1H, dd, J ) 12, 5.3 Hz,
H-3), 4.74 (1H, s, H-17), 4.78 (1H, d, J ) 2 Hz, H-17); EIMS
m/z (rel int) 446 [M]+ (0.6), 386 (6), 344 (7), 326 (57), 311 (5),
284 (9), 266 (100), 251 (69), 238 (12), 225 (21), 223 (21);
HREIMS m/z 446.2672 (calcd for C26H38O6, 446.2668).
Ca n d itr iol (11): 1H NMR (CDCl3, 500 MHz) δ 0.71 (1H,
td, J ) 13.2, 3.4 Hz, H-1â), 0.74 (H-19), 1.04 (1H, d, J ) 9 Hz,
H-9), 1.29 (1H, dd, J ) 12.6, 1.0 Hz, H-5), 1.63 (1H, dd, J ) 2
Hz, H-14), 1.79 (1H, dt, J ) 13.2, 3 Hz, H-1R), 2.03 (1H, dd, J
) 12.1, 5.3 Hz, H-14), 2.82 (1H, br s, H-13), 3.06 and 3.47 (each
1H, d, J ) 11.0 Hz, H-18), 3.90 (1H, dd, J ) 11.1, 4.5 Hz, H-7),
4.08 (1H, br s, H-15), 5.08 and 5.15 (each 1H, s, H-17); EIMS
m/z (rel int) 320 [M]+ (87), 302 (63), 287 (29), 275 (32), 271
(61), 262 (61), 257 (27), 253 (19), 201 (16), 162 (35), 152 (28),
147 (30), 145 (27), 131 (26), 129 (21), 123 (66), 109 (100);
HREIMS m/z 320.2351 (calcd for C20H30O3, 320.2351).
Sid er itr iol (5). Acetylation and chromatography of the
fraction containing this metabolite gave the triacetate 6: 1H
NMR (CDCl3, 500 MHz) δ 0.79 (3H, s, H-19), 0.81 (1H, dd J )
13, 2 Hz, H-1â), 1.06 (3H, s, H-20), 1.29 (1H, dd, J ) 10.3, 3.6
Hz, H-3â), 1.36 (1H, d, J ) 6 Hz, H-9), 1.47 (1H, m, H-12),
1.56 (1H, d, J ) 12.2 Hz, H-6â), 1.6 (1H, m, H-5), 1.75 (1H,
dd, J ) 12.2, 3.1 Hz, H-6R), 1.80 (1H, dt, J ) 13, 3 Hz, H-1R),
2.00 (1H, d, J ) 8.2 Hz, H-14), 2.03, 2.05 and 2.06 (each 3H,
s, OAc), 2.58 (1H, br s, H-13), 3.63 and 3.70 (each 1H, J )
12.0 Hz, H-18), 4.55 and 4.65 (each 1H, J ) 14.0 Hz, H-17),
4.73 (1H, br s, H-7), 5.56 (1H, s, H-15); EIMS m/z (rel int) 446
[M]+ (1), 404 (3), 386 (13), 371 (7), 344 (74), 326 (86), 313 (21),
284 (16), 266 (69), 253 (100), 238 (21), 225 (30), 223 (29), 209
(18), 197 (23), 183 (25), 169 (23), 157 (26), 145 (41); HREIMS
m/z 446.2666 (calcd for C26H38O6, 446.2668).
7r,16r,17,18-Tetr a h yd r oxy-en t-k a u r a n e (12). This com-
pound was obtained as its triacetate 13 and its tetraacetate
14 by acetylation and chromatography of the fraction contain-
ing it (see above).
Tr ia ceta te 13: colorless crystals; mp 139-141 °C; IR
(CHCl3) νmax 3500, 2935, 1735, 1375, 1250, 1040, 755 cm-1
;
1H NMR (CDCl3, 500 MHz) δ 0.71 (1H, td, J ) 13.3, 4.3 Hz,
H-1â), 0.78 (3H, s, H-19), 1.05 (3H, s, H-20), 1.07 (1H, d, J )
7.6 Hz, H-9), 1.25 (1H, d, J ) 12.1 Hz, H-5), 1.61 (2H, m, H-14
and H-15), 1.74 (1H, dt, J ) 12.9, 2.8 Hz, H-1R), 2.01 (1H, m,
H-13), 2.13 (1H, dd, J ) 11.9, 5.2 Hz, H-14), 3.55 and 3.79
(each 1H, J ) 11 Hz, H-18), 4.64 (1H, dd, J ) 11.4, 4.3 Hz,
H-7), 4.13 and 4.22 (each 1H, J ) 11.5 Hz, H-17); EIMS m/z
(rel int) 446 (1), 386 (24), 344 (100), 326 (65), 284 (71), 269
(29), 266 (76), 253 (96), 237 (20); 223 (31); HREIMS m/z
446.2706 (calcd for C26H38O6, 446.2668).
7â,16r,17,18-Tetr a h yd r oxy-en t-k a u r a n e (7). This com-
pound was obtained as the triacetate 8 and tetraacetate 9 by
acetylation and chromatography of the fraction containing it.
Tr ia ceta te 8: colorless crystals; mp 155-158 °C; IR (CHCl3)
1
νmax 3495, 2935, 1735, 1370, 1250, 1040, 755 cm-1; H NMR
(CDCl3, 500 MHz) δ 0.78 (3H, s, H-19), 0.79 (1H, td, J ) 13.3,
3 Hz, H-1â), 1.04 (3H, s, H-20), 1.28 (1H, dd, J ) 11, 3.5 Hz,
H-14), 1.41 (1H, d, J ) 7.02 Hz, H-9), 1.57 (2H, m, H-15), 1.83
(1H, br d, J ) 11 Hz, H-14), 2.01, 2.08 and 2.14 (each 3H, s,
OAc), 2.06 (1H, m, H-13), 3.61 and 3.68 (each 1H, J ) 11.2
Hz, H-18), 4.18 (2H, s, H-17), 4.79 (1H, br s, H-7R); EIMS m/z
(rel int) 464 [M]+ (6), 446 (15), 404 (23), 344 (90), 331 (79),
313 (29), 284 (26), 271 (100), 253 (42), 225 (26), 145 (19), 119
(21), 109 (32); HREIMS m/z 464.27869 (calcd for C26H40O7,
464.27740).
Tetr a a ceta te 14: colorless needles; mp 169-171 °C; 1H
NMR (CDCl3, 500 MHz) δ 0.73 (1H, td, J ) 13.3, 3.8 Hz, H-1â),
0.77 (3H, s, H-19), 1.04 (3H, s, H-20), 1.10 (1H, d, J ) 8.1 Hz,
H-9), 1.24 (1H, d, J ) 14.8 Hz, H-5), 1.52 and 2.08 (each 1H,
d, J ) 14.8 Hz, H-15), 1.74 (1H, dt, J ) 12.9, 2 Hz, H-1R),
1.94 (1H, dd, J ) 14.7 and 4.3 Hz, H-14), 1.96, 2.00, 2.03, 2.05
(each 3H, s, -OAc), 2.53 (1H, d, J ) 2.9 Hz, H-13), 3.54 and
3.80 (each 1H, J ) 11.0 Hz, H-18), 4.58 (1H, d, J ) 11.1, 4.0
Hz, H-7â), 4.44 and 4.82 (each 1H, J ) 12.4 Hz, H-17); EIMS
m/z (rel int) 446 [M - H2O]+ (3), 404 (5), 386 (80), 373 (12),
344 (72), 326 (100), 313 (45), 284 (30), 266 (68), 253 (74), 225
(21), 197 (14), 157 (29); HREIMS m/z 446.26379 [M - AcOH]+
(calcd for C26H38O6, 446.26683).
Tetr a a ceta te 9: 1H NMR (CDCl3, 500 MHz) δ 0.78 (3H, s,
H-19) 0.84 (1H, td, J ) 13, 3.3 Hz, H-1â), 1.04 (3H, s, H-20),
1.29 (1H, m, H-3), 1.44 (1H, d, J ) 6.8 Hz, H-9), 1.52 (1H, dd,
J ) 11, 4.6 Hz, H-14), 1.70 (1H, dd, J ) 16.2, 3.8 Hz, H-15),
1.79 (1H, dd, J ) 13, 3 Hz, H-1R), 1.86 (1H, br d, J ) 11 Hz,
H-14), 1.96, 2.01, 2.02, 2.04 (each 3H, s, OAc), 1.98 (1H, m,
H-15), 2.53 (1H, d, J ) 2.8 Hz, H-13), 3.60 and 3.69 (each 1H,
d, J ) 11.1 Hz, H-18), 4.43 and 4.86 (each 1H, d, J ) 12.0 Hz,
H-17), 4.70 (1H, br s, H-7R); EIMS m/z (rel int) 446 [M -
AcOH]+ (6), 404 (15), 386 (49), 344 (85), 326 (92), 313 (62),
Ack n ow led gm en t. This work has been supported by the
SEUID, Ministry of Education and Culture, Spain (PB98-
0540). We are highly obliged to UAEM-PROMEP (Mexico) for
granting a postdoctoral fellowship to L. Alvarez and to